Prime Medicine, Inc. (PRME) shareholders
Close on Nov 17, 2026Market cap $696.49MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Robert Nelsen Joint filing with ARCH Venture Fund X, L.P. (10.40%), ARCH Venture Fund X Overage, L.P. (10.40%) and 9 more | 18,587,036 | 10.40% | 13D (active) amendment | Aug 7, 2025 |
| Alphabet Inc. Joint filing with Alphabet Holdings LLC (12.30%), XXVI Holdings Inc. (12.30%) and 3 more | 16,562,498 | 12.30% | 13G (passive) amendment | Sep 30, 2025 |
| Bristol-Myers Squibb Company | 11,006,163 | 8.40% | 13G (passive) | Sep 30, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PRME | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Alphabet Inc. | 16,562,498 | 9.13% | $61.12M | – | 0.06% |
| BlackRock, Inc. | 9,602,041 | 5.29% | $35.43M | +1,100,333 | 0.00% |
| ARK Investment Management LLC | 8,348,746 | 4.60% | $30.81M | +2,101,919 | 0.20% |
| State Street Corp | 7,576,460 | 4.18% | $27.96M | +1,231,335 | 0.00% |
| T. Rowe Price Investment Management, Inc. | 5,237,332 | 2.89% | $19.33M | −244,561 | 0.01% |
| Vanguard Capital Management LLC | 4,522,640 | 2.49% | $16.69M | +48,478 | 0.00% |
| Balyasny Asset Management L.P. | 3,969,082 | 2.19% | $14.65M | −154,283 | 0.02% |
| Goldman Sachs Group Inc | 3,430,518 | 1.89% | $12.66M | +2,460,093 | 0.00% |
| Casdin Capital, LLC | 3,167,175 | 1.75% | $11.69M | – | 0.58% |
| Woodline Partners LP | 3,003,904 | 1.66% | $11.08M | +591 | 0.03% |
| UBS Group AG | 2,794,689 | 1.54% | $10.31M | −93,729 | 0.00% |
| Geode Capital Management, LLC | 2,712,446 | 1.50% | $10.01M | −31,254 | 0.00% |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,412,984 | 1.33% | $8.90M | −527,809 | 0.01% |
| Nikko Asset Management Americas, Inc. | 2,407,018 | 1.33% | $8.86M | −533,775 | 0.11% |
| Citadel Advisors LLC | 2,054,543 | 1.13% | $7.58M | +1,718,185 | 0.00% |
| ADAR1 Capital Management, LLC | 1,997,552 | 1.10% | $7.37M | +24,270 | 0.34% |
| FMR LLC | 1,761,884 | 0.97% | $6.50M | −7,592 | 0.00% |
| Two Sigma Investments, LP | 1,524,511 | 0.84% | $5.63M | −48,300 | 0.00% |
| Redmile Group, LLC | 1,389,632 | 0.77% | $5.13M | −201,200 | 0.34% |
| Farallon Capital Management LLC | 1,240,843 | 0.68% | $4.58M | – | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 187 | 107M | 58.8% | 23 / 64 | 67 / 23 | 14M | 6M |
| Q1 2026 | 192 | 99M | 54.3% | 39 / 73 | 50 / 25 | 17M | 8M |
| Q4 2025 | 183 | 98M | 54.1% | 44 / 66 | 41 / 26 | 26M | 19M |
| Q3 2025 | 167 | 92M | 51.0% | 53 / 63 | 31 / 7 | 38M | 4M |
| Q2 2025 | 121 | 59M | 32.4% | 29 / 36 | 36 / 33 | 8M | 10M |
| Q1 2025 | 125 | 60M | 33.3% | 23 / 42 | 34 / 29 | 2M | 6M |
| Q4 2024 | 132 | 64M | 35.5% | 35 / 39 | 32 / 17 | 3M | 7M |
| Q3 2024 | 116 | 69M | 37.9% | 15 / 38 | 33 / 18 | 9M | 4M |
| Q2 2024 | 122 | 69M | 38.0% | 26 / 45 | 31 / 19 | 7M | 5M |
| Q1 2024 | 115 | 67M | 37.0% | 23 / 40 | 34 / 13 | 19M | 1M |
| Q4 2023 | 105 | 49M | 27.0% | 34 / 26 | 27 / 12 | 4M | 4M |
| Q3 2023 | 83 | 50M | 27.3% | 11 / 35 | 15 / 6 | 5M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
155 funds held PRME in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PRME | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | 7,513,485 | 4.14% | $21.94M | 1.41% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 5,226,317 | 2.88% | $19.29M | 0.18% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,120,450 | 1.72% | $11.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,509,092 | 1.38% | $9.26M | 0.01% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 1,357,362 | 0.75% | $5.01M | 0.05% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,300,373 | 0.72% | $4.80M | 0.00% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1,219,872 | 0.67% | $4.50M | 0.05% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,023,465 | 0.56% | $2.99M | 0.01% | Jul 31, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 783,011 | 0.43% | $2.89M | 0.06% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 723,775 | 0.40% | $2.67M | 0.02% | Jun 30, 2026 |
| iShares Biotechnology ETF | 670,021 | 0.37% | $2.47M | 0.03% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 569,953 | 0.31% | $2.02M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 527,260 | 0.29% | $1.87M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 520,855 | 0.29% | $1.85M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 312,342 | 0.17% | $1.15M | 0.08% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Allan Reine | Chief Executive Officer, Director | 125,000 | 0.07% | Feb 27, 2026 |
| Keith Michael Gottesdiener | See Remarks, Director | 4,361,078 | 2.40% | May 12, 2025 |
| Svetlana Ni Makhni | Chief Financial Officer | – | – | Apr 17, 2026 |
| Carman Alenson | See Remarks | – | – | Feb 24, 2026 |
| Ann L. Lee | Chief Technical Officer | 100,000 | 0.06% | Feb 24, 2026 |
| Richard Brudnick | Chief Business Officer | 20,000 | 0.01% | May 22, 2025 |
| Meredith Goldwasser | SVP, Strategy & Corporate Ops. | 176,917 | 0.10% | Mar 3, 2025 |
| Jeremy Duffield | Chief Scientific Officer | 965,001 | 0.53% | Mar 3, 2025 |
| Wendy Chung | Director | – | – | Jun 8, 2026 |
| Robert Nelsen | Director, 10% owner | 18,502,974 | 10.20% | Jun 8, 2026 |
| Kaye I. Foster-Cheek | Director | – | – | Jun 8, 2026 |
| David P. Schenkein | Director | – | – | Jun 8, 2026 |
| Michael Aaron Kelly | Director | – | – | Jun 8, 2026 |
| Thomas Cahill | Director | 5,305,679 | 2.93% | Jun 8, 2026 |
| Jeffrey D. Marrazzo | Director | – | – | Jun 8, 2026 |
| Inc. Alphabet | 10% owner | 3,262,440 | 1.80% | Aug 5, 2025 |
| Gv 2021, L.P. | 10% owner | 12,497,764 | 6.89% | Aug 5, 2025 |
| Gv 2021 Gp, L.L.C. | 10% owner | 12,153,269 | 6.70% | Aug 5, 2025 |
| Gv 2021 Gp, L.P. | 10% owner | 11,862,498 | 6.54% | Aug 5, 2025 |
| ARCH Venture Fund X, L.P. | 10% owner | – | – | Aug 1, 2025 |
| ARCH Venture Partners XII, LLC | 10% owner | 15,456,594 | 8.52% | Aug 1, 2025 |
| Keith Crandell | 10% owner | – | – | Aug 1, 2025 |
| ARCH Venture Partners X Overage, L.P. | 10% owner | – | – | Aug 1, 2025 |
| Kristina Burow | 10% owner | – | – | Aug 1, 2025 |
| ARCH Venture Fund X Overage, L.P. | 10% owner | – | – | Aug 1, 2025 |
| ARCH Venture Fund XII, L.P. | 10% owner | 18,486,894 | 10.19% | Aug 1, 2025 |
| ARCH Venture Partners X, LLC | 10% owner | 11,856,594 | 6.54% | Aug 1, 2025 |
| ARCH Venture Partners XII, L.P. | 10% owner | – | – | Aug 1, 2025 |
| Steven Gillis | 10% owner | 18,486,894 | 10.19% | Aug 1, 2025 |
| ARCH Venture Partners X, L.P. | 10% owner | 15,456,594 | 8.52% | Aug 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Inc. Alphabet 10% owner | Aug 1, 2025 | Buy | +1,500,000 | $3.30 | $4.95M | 3,262,440 |
| Robert Nelsen Director, 10% owner | Aug 1, 2025 | Buy | +3,030,300 | $3.30 | $10.00M | 6,230,300 |
| Steven Gillis 10% owner | Aug 1, 2025 | Buy | +3,030,300 | $3.30 | $10.00M | 6,230,300 |
| ARCH Venture Fund XII, L.P. 10% owner | Aug 1, 2025 | Buy | +3,030,300 | $3.30 | $10.00M | 6,230,300 |
| David R. Liu 10% owner | Jun 30, 2025 | Buy | +21,000 | $2.52 | $52.92K | 20,240,945 |
| David R. Liu 10% owner | Jun 23, 2025 | Buy | +21,000 | $2.16 | $45.36K | 20,219,945 |
| David R. Liu 10% owner | Jun 16, 2025 | Buy | +21,000 | $1.49 | $31.29K | 20,198,945 |
| David R. Liu 10% owner | Jun 11, 2025 | Buy | +21,000 | $1.60 | $33.60K | 20,177,945 |
| Ann L. Lee Chief Technical Officer | May 21, 2025 | Buy | +100,000 | $1.13 | $113.00K | 100,000 |
| Allan Reine Chief Executive Officer, Director | May 21, 2025 | Buy | +125,000 | $1.18 | $147.50K | 125,000 |
| Richard Brudnick Chief Business Officer | May 20, 2025 | Buy | +20,000 | $1.19 | $23.80K | 20,000 |
| Keith Michael Gottesdiener See Remarks, Director | Oct 8, 2024 | Gift | +226,925 | – | – | 682,259 |
| Keith Michael Gottesdiener See Remarks, Director | Oct 8, 2024 | Gift | −226,925 | – | – | 50,241 |
| Keith Michael Gottesdiener See Remarks, Director | Jun 5, 2024 | Gift | −250,000 | – | – | 2,310,837 |
| Keith Michael Gottesdiener See Remarks, Director | Jun 5, 2024 | Gift | +250,000 | – | – | 277,166 |
| ARCH Venture Partners XII, LLC 10% owner | Feb 15, 2024 | Buy | +3,200,000 | $6.25 | $20.00M | 3,200,000 |
| Robert Nelsen Director, 10% owner | Feb 15, 2024 | Buy | +3,200,000 | $6.25 | $20.00M | 3,200,000 |
| ARCH Venture Partners X, L.P. 10% owner | Feb 15, 2024 | Buy | +3,200,000 | $6.25 | $20.00M | 3,200,000 |
| Keith Michael Gottesdiener See Remarks, Director | Nov 11, 2023 | Gift | −5,000 | – | – | 27,166 |
| Keith Michael Gottesdiener See Remarks, Director | Nov 11, 2023 | Gift | −7,500 | – | – | 2,560,837 |
| David R. Liu 10% owner | Jul 21, 2023 | Gift | −1,000,000 | – | – | 20,156,945 |
| David R. Liu 10% owner | Jul 21, 2023 | Gift | −1,000,000 | – | – | 20,156,945 |
| Gv 2021 Gp, L.P. 10% owner | Jun 21, 2023 | Sale(10b5-1 plan) | −19,003 | $14.97 | $284.47K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 21, 2023 | Other | −19,003 | – | – | 10,100,058 |
| Gv 2021 Gp, L.P. 10% owner | Jun 20, 2023 | Other | −37,405 | – | – | 10,119,061 |
| Gv 2021 Gp, L.P. 10% owner | Jun 20, 2023 | Sale(10b5-1 plan) | −37,405 | $15.06 | $563.32K | 0 |
| Inc. Alphabet 10% owner | Jun 16, 2023 | Other | −6,532 | – | – | 10,156,466 |
| Inc. Alphabet 10% owner | Jun 16, 2023 | Sale(10b5-1 plan) | −6,532 | $15.02 | $98.11K | 0 |
| Inc. Alphabet 10% owner | Jun 15, 2023 | Sale(10b5-1 plan) | −66,659 | $14.92 | $994.55K | 0 |
| Inc. Alphabet 10% owner | Jun 15, 2023 | Other | −66,659 | – | – | 10,162,998 |
| Gv 2021 Gp, L.P. 10% owner | Jun 14, 2023 | Sale(10b5-1 plan) | −28,960 | $14.87 | $430.64K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 14, 2023 | Other | −28,960 | – | – | 10,229,657 |
| Gv 2021 Gp, L.P. 10% owner | Jun 13, 2023 | Other | −28,100 | – | – | 10,258,617 |
| Gv 2021 Gp, L.P. 10% owner | Jun 13, 2023 | Sale(10b5-1 plan) | −28,100 | $15.13 | $425.15K | 0 |
| Gv 2019 Gp, L.L.C. 10% owner | Jun 12, 2023 | Sale(10b5-1 plan) | −16,031 | $14.98 | $240.14K | 0 |
| Gv 2019 Gp, L.L.C. 10% owner | Jun 12, 2023 | Other | −16,031 | – | – | 10,286,717 |
| Gv 2019 Gp, L.L.C. 10% owner | Jun 9, 2023 | Other | −15,672 | – | – | 10,302,748 |
| Gv 2019 Gp, L.L.C. 10% owner | Jun 9, 2023 | Sale(10b5-1 plan) | −15,672 | $14.48 | $226.93K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 8, 2023 | Sale(10b5-1 plan) | −5,000 | $15.74 | $78.70K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 8, 2023 | Other | −5,000 | – | – | 10,318,420 |
| Gv 2021 Gp, L.P. 10% owner | Jun 7, 2023 | Other | −15,000 | – | – | 10,323,420 |
| Gv 2021 Gp, L.P. 10% owner | Jun 7, 2023 | Sale(10b5-1 plan) | −15,000 | $16.92 | $253.80K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 6, 2023 | Other | −29,975 | – | – | 10,338,420 |
| Gv 2021 Gp, L.P. 10% owner | Jun 6, 2023 | Sale(10b5-1 plan) | −29,975 | $17.02 | $510.17K | 0 |
| Gv 2021 Gp, L.P. 10% owner | Jun 5, 2023 | Other | −22,434 | – | – | 10,368,395 |
| Gv 2021 Gp, L.P. 10% owner | Jun 5, 2023 | Sale(10b5-1 plan) | −22,434 | $16.70 | $374.65K | 0 |
| Gv 2021 Gp, L.L.C. 10% owner | Jun 1, 2023 | Other | −45,223 | – | – | 10,390,829 |
| Gv 2021 Gp, L.L.C. 10% owner | Jun 1, 2023 | Sale(10b5-1 plan) | −471 | $14.75 | $6.95K | 0 |
| Gv 2021 Gp, L.L.C. 10% owner | Jun 1, 2023 | Sale(10b5-1 plan) | −44,752 | $14.35 | $642.19K | 471 |
| Gv 2021 Gp, L.L.C. 10% owner | May 31, 2023 | Other | −16,633 | – | – | 10,436,052 |
| Gv 2021 Gp, L.L.C. 10% owner | May 31, 2023 | Sale(10b5-1 plan) | −16,633 | $13.65 | $227.04K | 0 |
| Gv 2019 Gp, L.L.C. 10% owner | May 30, 2023 | Sale(10b5-1 plan) | −16,805 | $13.70 | $230.23K | 0 |
| Gv 2019 Gp, L.L.C. 10% owner | May 30, 2023 | Other | −16,805 | – | – | 10,452,685 |
| Gv 2019 Gp, L.L.C. 10% owner | May 26, 2023 | Sale(10b5-1 plan) | −12,602 | $13.70 | $172.65K | 0 |
| Gv 2019 Gp, L.L.C. 10% owner | May 26, 2023 | Other | −12,602 | – | – | 10,469,490 |
| Inc. Alphabet 10% owner | May 25, 2023 | Other | −23,161 | – | – | 10,482,092 |
| Inc. Alphabet 10% owner | May 25, 2023 | Sale(10b5-1 plan) | −23,161 | $13.38 | $309.89K | 0 |
| Inc. Alphabet 10% owner | May 24, 2023 | Other | −7,900 | – | – | 10,505,253 |
| Inc. Alphabet 10% owner | May 24, 2023 | Sale(10b5-1 plan) | −7,900 | $13.66 | $107.91K | 0 |
| Inc. Alphabet 10% owner | May 23, 2023 | Sale(10b5-1 plan) | −43,939 | $14.74 | $647.66K | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Prime Medicine's stock actually held short. Settlement fails (shares not delivered on time) peaked at 153,560 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Alphabet Holdings LLC 10% Stockholder | Jun 20, 2023 | 522,561 | $7.79M | Jun 20, 2023 | Stock Purchase |
| Alphabet Holdings LLC 10% Stockholder | Jun 12, 2023 | 159,596 | $2.31M | Jun 12, 2023 | STOCK PURCHASE |
| Alphabet Holdings LLC 10% Stockholder | Jun 5, 2023 | 88,081 | $1.42M | Jun 5, 2023 | Stock Purchase |
| Alphabet Holdings LLC 10% Stockholder | May 30, 2023 | 71,263 | $974.17K | May 30, 2023 | stock purchase |
| Alphabet Holdings LLC 10% Stockholder | May 18, 2023 | 260,156 | $3.39M | May 18, 2023 | STOCK PURCHASE |
| Gv 2021, L.P. 10% Stockholder | May 8, 2023 | 1,121,197 | $16.06M | May 8, 2023 | STOCK PURCHASE |
See a number that looks wrong?